As the US headquarters of German drug maker Boehringer Ingelheim, Boehringer Ingelheim Corporation oversees about half a dozen stateside subsidiaries that produce and sell drugs (both prescription and over-the-counter), animal health products, and chemicals for the US market. It sells its prescription and OTC products through its largest unit Boehringer Ingelheim Pharmaceuticals. Additionally, the firm's Roxane Laboratories makes generic drugs and its Ben Venue Laboratories is a contract pharmaceutical manufacturer and provides drug development services to other pharmaceutical companies.
The company has operations in Ridgefield, Connecticut; Cleveland and Columbus, Ohio; St. Joseph, Missouri; Fremont, California; and Petersburg, Virginia.
The company's Boehringer Ingelheim Vetmedica unit is a leading US maker of health products for farm animals and pets, while Boehringer Ingelheim Chemicals produces active pharmaceutical ingredients used in drugmaking.
Through its Pharmaceuticals subsidiary, Boehringer Ingelheim Corporation serves as one of its parent company's major research centers, with particular focus on cardiovascular disease, immunology, and inflammatory conditions.